+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoprotein Market - Global Forecast 2026-2032- Product Image
Immunoprotein Market - Global Forecast 2026-2032- Product Image
New

Immunoprotein Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5532790
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunoprotein market is undergoing significant transformation, shaped by rapid technological advancements and evolving clinical requirements that increasingly influence commercial strategies and patient care delivery. Senior decision-makers now face a dynamic landscape marked by both operational pressures and opportunities for innovation in diagnostics and therapeutics.

Market Snapshot: Immunoprotein Market Growth and Competitive Dynamics

The Immunoprotein Market advanced from USD 23.61 billion in 2025 to USD 25.89 billion in 2026 and is projected to achieve USD 47.97 billion by 2032, demonstrating a CAGR of 10.65%. This robust growth is driven by the expanding utility of immunoproteins across clinical uses, the maturation of biosimilar options, and increased adoption in both diagnostic and therapeutic applications. As manufacturers respond with heightened product innovation, focus intensifies on maintaining supply chain resilience and navigating a more intricate competitive environment encompassing diagnostic developers, producers, and solution providers.

Scope & Segmentation of the Immunoprotein Market

This analysis offers comprehensive segmentation and worldwide coverage to support strategic planning and market positioning:

  • Product Formulations: Intramuscular, intravenous (including branded, generic, hypoimmune, and next-generation), and subcutaneous immunoglobulin (conventional and facilitated) formats are available, each presenting specific manufacturing, delivery, and adoption considerations.
  • Analytical Technologies: Key validation and clinical decision-making technologies comprise capillary electrophoresis, enzyme-linked immunosorbent assay, liquid chromatography mass spectrometry, protein microarray, and surface plasmon resonance, providing essential value in both development and application.
  • Clinical Applications: Acute and chronic care contexts are addressed, spanning autoimmune, hematological, immunodeficiency, infectious, and neurological conditions, with requirements for precise diagnostic and therapeutic monitoring integrated throughout.
  • End-User Settings: The segment includes diagnostic centers, hospitals, specialty clinics, home healthcare, and research laboratories, each requiring tailored operational and regulatory approaches as well as targeted training regimes.
  • Regional Markets: The Americas, Europe, Middle East & Africa, and Asia-Pacific each present distinctive commercialization needs and require localized compliance strategies to navigate variable regulatory, reimbursement, and demand profiles.

Key Takeaways for Senior Decision-Makers

  • Innovations in assay sensitivity and bioprocessing are redefining clinical and operational differentiation, strengthening the reliability and applicability of immunoproteins in fast-evolving diagnostic and therapeutic settings.
  • The move toward decentralized care models, including expanded outpatient and home-based administration, is broadening access, and changing the logistics, patient engagement, and supply network requirements for all stakeholders.
  • Continuous regulatory evolution—particularly the development of granular guidance for next-generation biosimilars—signals increased investment in advanced formulations and fuels demand for regionally focused partnerships.
  • Integrated workflows such as multiplexed biomarker panels enable more streamlined and precise diagnostic operations, supporting improved patient stratification and value demonstration in payer discussions.
  • Collaboration across manufacturers, diagnostic technology firms, and specialty clinical settings underpins value optimization in adoption, clinical evidence generation, and alignment with payer expectations.
  • To facilitate global expansion and quality assurance, strategies must address marked regional disparities, including differences in reimbursement mechanisms and the timing of regulatory approvals.

Tariff Impact and Supply Chain Reconfiguration

Variable tariff policies continue to impact the immunoprotein value chain by affecting raw material procurement, reagent importation, and movement of finished products between distribution hubs. In response, manufacturers are reassessing sourcing strategies, bolstering domestic supplier qualifications, and adjusting distribution plans to foster operational resilience. Healthcare providers, research institutions, and procurement teams are adapting by reallocating budgets and placing preference on products that streamline logistics and enable effective regional stockpiling. These shifts are directly influencing market access and driving modifications in purchasing patterns as organizations prioritize supply continuity and cost-effectiveness in uncertain geopolitical climates.

Methodology & Data Sources

This report employs primary interviews with clinical experts, laboratory directors, and commercial strategists, complemented by thorough reviews of regulatory guidance documents, peer-reviewed scientific literature, and recognized technical standards. Method-specific evaluations support analytical conclusions across all featured immunoprotein technologies.

Why This Report Matters

  • Empowers informed investment, partnership, and sourcing decisions by mapping differentiation across immunoprotein products, enabling technologies, and regional landscapes.
  • Equips senior leaders with actionable insights for clinical integration, regulatory compliance, and proactive operational risk management spanning multiple geographies and market conditions.
  • Provides a trusted knowledge resource for aligning organizational objectives with evolving market trends, supporting both commercial and clinical value delivery.

Conclusion

Success in the immunoprotein sector depends on harmonizing technical advances, operational feasibility, and stakeholder collaboration. This structured analysis supports strategic navigation of emerging challenges and new opportunities in this rapidly evolving market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Immunoprotein Market, by Product
8.1. Intramuscular Immunoglobulin
8.2. Intravenous Immunoglobulin
8.2.1. Branded
8.2.2. Generic
8.2.3. Hypoimmune
8.2.4. Next Generation
8.3. Subcutaneous Immunoglobulin
8.3.1. Conventional
8.3.2. Facilitated
9. Immunoprotein Market, by Technology
9.1. Capillary Electrophoresis
9.2. Enzyme Linked Immunosorbent Assay
9.3. Liquid Chromatography Mass Spectrometry
9.4. Protein Microarray
9.5. Surface Plasmon Resonance
10. Immunoprotein Market, by Application
10.1. Diagnostic
10.1.1. Disease Marker Detection
10.1.2. Immune Response Assessment
10.1.3. Pharmacokinetic Studies
10.2. Therapeutic
10.2.1. Autoimmune Disorders
10.2.2. Hematological Disorders
10.2.3. Immunodeficiency Disorders
10.2.4. Infectious Diseases
10.2.5. Neurological Disorders
11. Immunoprotein Market, by End User
11.1. Diagnostic Centers
11.2. Home Healthcare Settings
11.3. Hospitals
11.4. Research Laboratories
11.5. Specialty Clinics
12. Immunoprotein Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Immunoprotein Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Immunoprotein Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Immunoprotein Market
16. China Immunoprotein Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Becton, Dickinson and Company
17.7. Bio-Rad Laboratories, Inc.
17.8. CSL Behring LLC
17.9. Danaher Corporation
17.10. DiaSorin S.p.A.
17.11. Fujirebio Inc.
17.12. Grifols, S.A.
17.13. Hologic, Inc.
17.14. Octapharma AG
17.15. Ortho Clinical Diagnostics Holdings plc
17.16. QuidelOrtho Corporation
17.17. Roche Holding AG
17.18. Siemens Healthineers AG
17.19. Thermo Fisher Scientific Inc.
17.20. Werfen, S.A.
List of Figures
FIGURE 1. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES IMMUNOPROTEIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA IMMUNOPROTEIN MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HYPOIMMUNE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HYPOIMMUNE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HYPOIMMUNE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEXT GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEXT GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEXT GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY FACILITATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY FACILITATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY FACILITATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PROTEIN MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PROTEIN MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISEASE MARKER DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISEASE MARKER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISEASE MARKER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNE RESPONSE ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNE RESPONSE ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNE RESPONSE ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNODEFICIENCY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNODEFICIENCY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNODEFICIENCY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 136. EUROPE IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 137. EUROPE IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 138. EUROPE IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. EUROPE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 141. EUROPE IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 142. EUROPE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 154. AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 155. AFRICA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 156. AFRICA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. AFRICA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 159. AFRICA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 160. AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 173. ASEAN IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 174. ASEAN IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 175. ASEAN IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. ASEAN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. ASEAN IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 178. ASEAN IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 179. ASEAN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GCC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GCC IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 182. GCC IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 183. GCC IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 184. GCC IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. GCC IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. GCC IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 187. GCC IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 188. GCC IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. BRICS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. BRICS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 200. BRICS IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 201. BRICS IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 202. BRICS IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. BRICS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. BRICS IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 205. BRICS IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 206. BRICS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. G7 IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. G7 IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 209. G7 IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 210. G7 IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 211. G7 IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. G7 IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. G7 IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 214. G7 IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 215. G7 IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. NATO IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. NATO IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 218. NATO IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 219. NATO IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 220. NATO IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. NATO IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. NATO IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 223. NATO IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 224. NATO IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES IMMUNOPROTEIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. CHINA IMMUNOPROTEIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. CHINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 237. CHINA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 238. CHINA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 239. CHINA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. CHINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. CHINA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 242. CHINA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 243. CHINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Immunoprotein market report include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • CSL Behring LLC
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Fujirebio Inc.
  • Grifols, S.A.
  • Hologic, Inc.
  • Octapharma AG
  • Ortho Clinical Diagnostics Holdings plc
  • QuidelOrtho Corporation
  • Roche Holding AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Werfen, S.A.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 25.89 Billion
Forecasted Market Value ( USD ) by 2032 $ 47.97 Billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market - Global Forecast 2026-2032 - Product Image

Immunoprotein Diagnostic Testing Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Immunoprotein Diagnostic Testing - Global Strategic Business Report - Product Image

Immunoprotein Diagnostic Testing - Global Strategic Business Report

  • Report
  • 171 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
2025 World Clinical Chemistry and Immunodiagnostics Markets for 120 Individual Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM Tests in the US, Europe, Japan - Supplier Shares, Volume/Sales Segment Forecasts, Test Methods, New Product Opportunities - Product Image

2025 World Clinical Chemistry and Immunodiagnostics Markets for 120 Individual Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM Tests in the US, Europe, Japan - Supplier Shares, Volume/Sales Segment Forecasts, Test Methods, New Product Opportunities

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From

About the Immunoprotein Market

The Immunoprotein market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It is used to detect and measure the presence of antigens and antibodies in a patient's sample. Immunoprotein tests are used to diagnose a variety of conditions, including autoimmune diseases, allergies, infections, and cancer. These tests are also used to monitor the effectiveness of treatments. Immunoprotein tests are typically performed in a laboratory setting, and the results are used to inform clinical decisions. The tests are highly sensitive and specific, and they can be used to detect even small amounts of antigens or antibodies. The Immunoprotein market is expected to continue to grow as more tests become available and as the demand for IVD tests increases. This growth is driven by the increasing prevalence of chronic diseases, the need for more accurate and timely diagnosis, and the development of new technologies. Some of the major players in the Immunoprotein market include Abbott Laboratories, Bio-Rad Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.